News
GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan ...
Ozempic is an FDA-approved medication for people with type 2 diabetes. It’s often prescribed off-label for weight loss — that ...
GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...
Infection, delayed kidney function, kidney loss and death are all risks associated with kidney transplant surgery in obese ...
Semaglutide is linked to a reduced risk for Alzheimer’s disease-related dementia in patients with diabetes vs other antidiabetic drugs, a new study suggests.
The European Medicines Agency (EMA) has warned that popular weight-loss and diabetes drugs containing semaglutide — including ...
Sprout Health is an online prescriber of weight loss medications. Currently, the only medication available is a compounded semaglutide injection that’s shipped to patients monthly with no membership ...
7d
Daily Voice on MSNPlainsboro-Based Wegovy Provider Ends Hims & Hers Deal Over Knockoff Weight-Loss Drug SalesNovo Nordisk has ended its partnership with Hims & Hers Health after two months, accusing the telehealth company of pushing ...
As the NHS rolls out Mounjaro being prescribed by GPs, weight loss jabs have been linked to potentially fatal side effects in ...
In combination with Eli Lilly’s tirzepatide, marketed as Zepbound for obesity, Scholar Rock’s monolonal antibody helped ...
4d
Study Finds on MSNTaking Semaglutide Could Cut Dementia Risk Nearly In Half, Case Western Study ShowsBeyond helping diabetes patients lose weight and control blood sugar, semaglutide appears to cut dementia risk by nearly half ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results